​

ANI Pharmaceuticals Ownership | Who Owns ANI Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

ANI Pharmaceuticals Ownership Summary

ANI Pharmaceuticals is owned by 97.37% institutional investors, 11.12% insiders. Blackrock is the largest institutional shareholder, holding 13.91% of ANIP shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 5.09% of its assets in ANI Pharmaceuticals shares.

ANIP Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockANI Pharmaceuticals97.37%11.12%-8.49%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustrySpecialty & Generic Drug Manufacturers Stocks34.90%10.53%54.58%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock2.66M13.91%$169.17M
Vanguard group1.44M7.54%$91.73M
State street645.14K3.38%$41.08M
Dimensional fund advisors lp630.23K3.30%$40.13M
Rubric capital management lp603.80K3.16%$38.45M
Global alpha capital management526.95K2.76%$33.56M
William blair investment management489.39K2.56%$31.16M
Deep track capital, lp466.09K2.44%$29.68M
Tang capital management450.00K2.36%$28.66M
Geode capital management407.91K2.14%$25.98M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management450.00K2.92%$28.66M
Global alpha capital management526.95K2.45%$33.56M
Ranger investment management402.73K1.74%$25.65M
Marathon capital management70.30K1.14%$4.48M
Rubric capital management lp603.80K1.01%$38.45M
Deep track capital, lp466.09K0.89%$29.68M
Lisanti capital growth51.10K0.78%$3.25M
Virtus investment advisers12.32K0.66%$784.47K
Perkins capital management9.19K0.55%$585.00K
Kings path partners16.33K0.49%$1.04M

Top Buyers

HolderShares% AssetsChange
Tang capital management450.00K2.92%300.00K
Millennium management230.08K0.01%209.27K
Macquarie group388.08K0.03%174.18K
Global alpha capital management526.95K2.45%136.20K
Vanguard group1.44M0.00%134.01K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp466.09K0.89%-355.91K
Rubric capital management lp603.80K1.01%-354.73K
Susquehanna group, llp---226.40K
Weiss asset management lp---76.51K
Sio capital management---71.74K

New Positions

HolderShares% AssetsChangeValue
First trust advisors lp61.78K0.00%61.78K$3.93M
Segall bryant & hamill44.13K0.05%44.13K$2.81M
Quantedge capital pte21.20K0.49%21.20K$1.35M
Kings path partners16.33K0.49%16.33K$1.04M
Natixis advisors11.64K0.00%11.64K$741.00K

Sold Out

HolderChange
Financial gravity asset management-1.00
Fifth third bancorp-2.00
Farther finance advisors-3.00
Nelson, van denburg & campbell wealth management group-3.00
Yhb investment advisors-15.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20242091.95%18,894,59324.90%971.55%12516.82%43-30.65%
Jun 30, 2024203-1.46%15,126,9587.17%791.45%105-2.78%6219.23%
Mar 31, 202420612.57%14,115,5553.76%731.44%10825.58%52-
Dec 31, 2023183-2.66%13,603,4943.16%711.47%86-16.50%521.96%
Sep 30, 20231888.67%13,186,5067.85%691.46%103-11.97%51121.74%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF1.07M5.09%552.00
Vanguard Total Stock Mkt Idx Inv589.09K2.80%841.00
Pacer US Small Cap Cash Cows 100 ETF551.51K2.62%-288.00
iShares Russell 2000 ETF506.17K2.41%-1.06K
Ranger Small Cap392.18K1.86%152.03K
Delaware Ivy Small Cap Growth C336.40K1.60%-
MEDICAL BioHealth EUR Acc255.97K1.22%-
Vanguard Institutional Extnd Mkt Idx Tr245.16K1.16%-800.00
CC&L Global Alpha - Series A240.50K1.14%-
Ranger Micro Cap197.51K0.94%41.68K

Recent Insider Transactions

DateNameRoleActivityValue
Dec 17, 2024CAREY STEPHEN P. SVP & CFOSell$418.43K
Dec 13, 2024Cook Meredith SR. VP, GENERAL COUNSEL & SEC.Sell$14.06K
Dec 11, 2024Davis Krista SVP, CHIEF HR OFFICERSell$60.00K
Nov 26, 2024Lalwani Nikhil PRESIDENT & CEOSell$1.74M
Nov 26, 2024Lalwani Nikhil PRESIDENT & CEOSell$202.94K

Insider Transactions Trends

DateBuySell
2024 Q4-8
2024 Q3-8
2024 Q2-24
2024 Q1-20
2023 Q4-19

ANIP Ownership FAQ

Who Owns ANI Pharmaceuticals?

ANI Pharmaceuticals shareholders are primarily institutional investors at 97.37%, followed by 11.12% insiders and -8.49% retail investors. The average institutional ownership in ANI Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 34.90%, which ANI Pharmaceuticals exceeds.

Who owns the most shares of ANI Pharmaceuticals?

ANI Pharmaceuticals’s largest shareholders are Blackrock (2.66M shares, 13.91%), Vanguard group (1.44M shares, 7.54%), and State street (645.14K shares, 3.38%). Together, they hold 24.83% of ANI Pharmaceuticals’s total shares outstanding.

Does Blackrock own ANI Pharmaceuticals?

Yes, BlackRock owns 13.91% of ANI Pharmaceuticals, totaling 2.66M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 169.17M$. In the last quarter, BlackRock increased its holdings by 125.17K shares, a 4.94% change.

Who is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is ANI Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 2.92% of its assets in 450K ANI Pharmaceuticals shares, valued at 28.66M$.

Who is the top mutual fund holder of ANI Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of ANI Pharmaceuticals shares, with 5.09% of its total shares outstanding invested in 1.07M ANI Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools